SecBot SecBot
6-K ·Filed Nov 5, 2026

PRE

Prenetics Global Ltd
BULLISH
Impact 6/10
Horizonmonths Processed12d 6h ago SEC0001628280-26-070655
Notable filing: 6-K
Actionable Insight ▲ Bullish

The partnership opens a large addressable market in gummy supplements and children's wellness, with pre-built brand awareness lowering customer acquisition costs. Monitor the 1H 2027 product launch and initial revenue contribution from Care Bears by IM8, which is not included in current guidance.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$16.12
T+0 close · Nov 5, 2026 · via day close
Latest settled
+3.72%
T+5 · $16.72
Vs SPY
+0.43%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $16.12entry
  2. T+1 · 11d ago −1.12%α −1.43% · $15.94
  3. T+5 · 5d ago +3.72%α +0.43% · $16.72
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Prenetics Global announced a 10-year exclusive global partnership with Authentic Brands Group to launch 'Care Bears by IM8', a family health and wellness brand starting with gummy multivitamins in 1H 2027. Authentic will become a strategic shareholder in Prenetics via an equity issuance. The company also raised its FY2026 revenue guidance to $220M-$230M and initiated 2027 IM8 revenue guidance of $400M+, both excluding any Care Bears contribution.

Key Financial Metrics

Guidance
$220M-$230M
raised

Key Facts

  • 10-year exclusive worldwide license agreement with Authentic Brands Group for Care Bears by IM8 brand
  • Authentic to become strategic shareholder in Prenetics via equity consideration (undisclosed amount)
  • Prenetics records all Care Bears by IM8 revenue and pays a royalty to Authentic
  • Global launch of gummy multivitamins for kids and adults targeted in 1H 2027
  • FY2026 revenue guidance raised to $220M-$230M (from prior undisclosed level)
  • 2027 IM8 revenue guidance initiated at $400M or more, excluding Care Bears by IM8
  • IM8 Q2 2026 revenue $45M, up ~359% YoY; July 2026 monthly revenue $20.9M ($251M annualized run-rate)
  • Global gummy supplements market projected to reach $47.8B by 2030 (14.4% CAGR)

Financial Impact

FY2026 revenue guidance raised to $220M-$230M; 2027 IM8 revenue guidance $400M+; Care Bears by IM8 represents incremental upside not in current guidance

revenueequity issuance

Risk Factors

  • Product launch delayed beyond 1H 2027 target
  • Execution risk in expanding from DTC to retail distribution
  • Guaranteed minimum royalty payments and letter of credit requirements create fixed cost obligations
  • Equity issuance to Authentic will dilute existing shareholders (amount undisclosed)
  • Care Bears by IM8 revenue excluded from guidance, making near-term financial impact uncertain

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001628280-26-070655
Document: care_bearsxbyxim8x-xpressx.htm0001628280-26-070655
Document: a6-kxcarebears.htm0001628280-26-070655
Document: 0001628280-26-070655-index-headers.html0001628280-26-070655
Document: 0001628280-26-070655-index.html0001628280-26-070655
Document: 0001628280-26-070655.txt0001628280-26-070655
Earnings Context (Synthetic; results releases only)0001628280-26-070655

Track record

25 reports on PRE

Performance horizon

8 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +46.08% at T+5 after the Aug 20, 2026 report. 11 of 12 went positive at some point.

Filters
  1. Nov 17, 2026today 6-K Bullish 5/10 Entry $15.50 Now $16.33 +5.35% settles Nov 24
  2. Nov 16, 20261d ago Press Release Bullish 5/10 Entry $16.51 Now $16.33 −1.09% settles Nov 23
  3. Nov 5, 202612d ago 6-K Bullish 6/10 Viewing Entry $16.12 to $16.72 Now $16.33 +1.30% ▲ +3.72% +0.43% vs SPY
  4. Nov 5, 202612d ago Press Release Bullish 6/10 Entry $16.12 to $16.72 Now $16.33 +1.30% ▲ +3.72% +0.43% vs SPY
  5. Nov 3, 202614d ago 6-K Neutral 3/10 Entry $16.19 to $17.23 Now $16.33 +0.86% ▲ +6.42% +7.01% vs SPY
  6. Nov 2, 202615d ago 6-K Neutral 3/10 Entry $16.47 to $17.55 Now $16.33 −0.85% ▲ +6.56% +6.48% vs SPY
  7. Oct 13, 20265w ago 6-K Bullish 5/10 Entry $21.27 to $18.63 Now $16.33 −23.23% ▼ −12.41% −11.26% vs SPY
  8. Sep 22, 20268w ago F-1/A Neutral 3/10 Entry $22.90 to $22.84 Now $16.33 −28.69% ▼ −0.26% +0.93% vs SPY
  9. Aug 26, 202611w ago 6-K Bullish 7/10 Entry $25.78 to $26.05 Now $16.33 −36.66% ▲ +1.05% +1.17% vs SPY
  10. Aug 26, 202611w ago Insider Cluster Bullish 5/10 Entry $25.78 to $26.05 Now $16.33 −36.66% ▲ +1.05% +1.17% vs SPY
Showing 10 of 25

US Market Status

Market Open · Closes in 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026